Zenocutuzumab Biosimilar - Research Grade

https://www.imgt.org/mAb-DB/

ICH3002

Zenocutuzumab is a research-grade, non-therapeutic biosimilar analog supplied as a bispecific antibody that simultaneously engages two receptor targets to disrupt growth-factor signaling, a strategy of interest in oncology research. It is intended strictly for research use only (RUO). Limited card details are provided, so this background describes only its established bispecific design without inventing further specifics. The reagent is purified to a low-endotoxin standard suitable for in vivo studies and produced in scalable milligram to gram quantities for bulk and high-throughput laboratories. It supports dual-target binding assays, in vitro screening, control work, and preclinical tumor-signaling models.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.